Catalyst Wire Dossier Catalyst Wire Dossier

PATADAY TWICE A DAY RELIEF

olopatadine hydrochloride · Alcon Laboratories, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PATADAY TWICE A DAY RELIEF, covering 2013-09-12 to 2025-04-15. Get the full timeline:

Most recent: FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

See pricing